Invention Grant
- Patent Title: Active cores of peptide triazole HIV-1 entry inhibitors
- Patent Title (中): 肽三唑HIV-1进入抑制剂的活性核心
-
Application No.: US13380422Application Date: 2010-06-24
-
Publication No.: US08575095B2Publication Date: 2013-11-05
- Inventor: Irwin M. Chaiken , Umashankara Muddegowda , Karyn McFadden
- Applicant: Irwin M. Chaiken , Umashankara Muddegowda , Karyn McFadden
- Applicant Address: US PA Philadelphia
- Assignee: Philadelphia Health & Education Corporation
- Current Assignee: Philadelphia Health & Education Corporation
- Current Assignee Address: US PA Philadelphia
- Agency: Riverside Law LLP
- International Application: PCT/US2010/039829 WO 20100624
- International Announcement: WO2010/151675 WO 20101229
- Main IPC: A61K38/04
- IPC: A61K38/04 ; A61K38/08
Abstract:
The invention provides a peptide triazole conjugate and derivatives thereof, and methods of its use. Further provided are an antibody to the peptide triazole conjugate, and a method of identifying an HIV-1 entry inhibitor candidate.
Public/Granted literature
- US20120165250A1 Active Cores of Peptide Triazole HIV-1 Entry Inhibitors Public/Granted day:2012-06-28
Information query
IPC分类:
